These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31320929)

  • 1. Burden of drug use for gastrointestinal symptoms and functional gastrointestinal disorders in France: a national study using reimbursement data for 57 million inhabitants.
    Tuppin P; Rivière S; Deutsch D; Gastaldi-Menager C; Sabaté JM
    Therap Adv Gastroenterol; 2019; 12():1756284819853790. PubMed ID: 31320929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic management of uncomplicated gastroesophageal reflux disease in france in 2005: Potential cost savings of omeprazole substitution.
    Mouly S; Charlemagne A; Lejeunne P; Fagnani F
    Curr Ther Res Clin Exp; 2009 Aug; 70(4):282-98. PubMed ID: 24683238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of rational nonsteroidal anti-inflammatory drugs and gastro-protective agents use; association rule data mining using outpatient prescription patterns.
    Pattanaprateep O; McEvoy M; Attia J; Thakkinstian A
    BMC Med Inform Decis Mak; 2017 Jul; 17(1):96. PubMed ID: 28676124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Switching of H(2)-Receptor Antagonists to Over-the-Counter Status in Finland : Implications for Consumption and Adverse Effects.
    Närhi U; Vanakoski J; Sihvo S
    Clin Drug Investig; 2005; 25(4):243-8. PubMed ID: 17523774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and economic burden of cardiovascular diseases in France in 2013 according to the national health insurance scheme database.
    Tuppin P; Rivière S; Rigault A; Tala S; Drouin J; Pestel L; Denis P; Gastaldi-Ménager C; Gissot C; Juillière Y; Fagot-Campagna A
    Arch Cardiovasc Dis; 2016; 109(6-7):399-411. PubMed ID: 27079468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitors and hospital discharge rates for gastrointestinal events in Italy: a national ecological study.
    Russo P; Brutti C
    Clin Ther; 2007 Apr; 29(4):751-8. PubMed ID: 17617299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homeopathy in France in 2011-2012 according to reimbursements in the French national health insurance database (SNIIRAM).
    Piolot M; Fagot JP; Rivière S; Fagot-Campagna A; Debeugny G; Couzigou P; Alla F
    Fam Pract; 2015 Aug; 32(4):442-8. PubMed ID: 25921648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of proton pump inhibitors in adults in France: a nationwide drug utilization study.
    Lassalle M; Le Tri T; Bardou M; Biour M; Kirchgesner J; Rouby F; Dumarcet N; Zureik M; Dray-Spira R
    Eur J Clin Pharmacol; 2020 Mar; 76(3):449-457. PubMed ID: 31838548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cohort study of therapeutic prescriptions after the end of phytotherapy drug reimbursement by French Social Security.
    Riou França L; Vidal C; Bourechak N; Jeunne PL; Deville GS; Massol J
    Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):760-8. PubMed ID: 23208799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feedback and lessons from the prescription of rimonabant, a drug to be used under strict guidelines, in southeastern France, March 2007 through June 2008.
    Jardin M; Cortaredona S; Bocquier A; Nauleau S; Sciortino V; Bouvenot J; Sauze L; Bouvenot G; Verger P
    Rev Epidemiol Sante Publique; 2011 Apr; 59(2):115-22. PubMed ID: 21435807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between gifts from pharmaceutical companies to French general practitioners and their drug prescribing patterns in 2016: retrospective study using the French Transparency in Healthcare and National Health Data System databases.
    Goupil B; Balusson F; Naudet F; Esvan M; Bastian B; Chapron A; Frouard P
    BMJ; 2019 Nov; 367():l6015. PubMed ID: 31690553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [General practitioners' management of gastroesophageal reflux in France in 2005: a pharmacoeconomic study].
    Mouly S; Charlemagne A; Le Jeunne P; Fagnani F
    Presse Med; 2008 Oct; 37(10):1397-406. PubMed ID: 18502602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug use for gastrointestinal symptoms during pregnancy: A French nationwide study 2010-2018.
    Meyer A; Fermaut M; Drouin J; Carbonnel F; Weill A
    PLoS One; 2021; 16(1):e0245854. PubMed ID: 33481904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dispensing of Potentially Harmful Prescription Drugs in 1.8 Million Pregnant Women in France: A Nationwide Study Based on Two Risk Classification Systems.
    Blotière PO; Damase-Michel C; Weill A; Maura G
    Drug Saf; 2021 Dec; 44(12):1323-1339. PubMed ID: 34613596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of proton pump inhibitors in general practice.
    Tosetti C; Nanni I
    World J Gastrointest Pharmacol Ther; 2017 Aug; 8(3):180-185. PubMed ID: 28828196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton pump inhibitors prescriptions in France: Main trends from 2006 to 2016 on French health insurance database.
    Boucherie Q; Rouby F; Frankel D; Roll P; Micallef J
    Therapie; 2018 Oct; 73(5):385-388. PubMed ID: 29778306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reimbursement of opiate substitution drugs to militaries in 2007].
    d'Argouges F; Desjeux G; Marsan P; Thevenin-Garron V
    Encephale; 2012 Sep; 38(4):304-9. PubMed ID: 22980471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The impact of the use of treatments not included in the reimbursement classes in the care of rare patients: a real world study.].
    Mazzucato M; Minichiello C; Visonà Dalla Pozza L; Vianello A; Toto E; De Lorenzi M; Scroccaro G; Facchin P
    Recenti Prog Med; 2022; 113(7):440-450. PubMed ID: 35852080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost analysis of a provincial drug program to guide the treatment of upper gastrointestinal disorders.
    Bursey F; Crowley M; Janes C; Turner CJ
    CMAJ; 2000 Mar; 162(6):817-23. PubMed ID: 10750472
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.